Abstract
To study the association between attention deficit hyperactivity disorder (ADHD) drug use and the incidence of hospitalization due to injuries. A random sample of 150,000 persons (0–18 years) was obtained from the Dutch PHARMO record linkage system. An ADHD medication cohort as well as an up to six age/sex/index date sampled control cohort with no history of ADHD drug use was formed. Differences in incidence of hospitalization due to injuries were stratified for age and sex and compared prior, during and after exposure on ADHD drugs. The overall incidence of hospital admissions for injuries was two times higher in the ADHD medication cohort [incidence rate ratios (IRR) 2.2 (95 % CI 1.6–2.9)]. The incidence rate for injuries during exposure to ADHD drugs was lower in the exposed period compared to the period prior to ADHD drug use, although the difference was not statistically significant [IRR 0.68 (95 % CI 0.29–1.60)]. The relative risk for injuries was almost five times higher in the ADHD medication cohort among those who concomitantly used other psychotropics [IRR 4.8 (95 % CI 1.4–16.9)]. Risk for injuries was highest in 12–18 years olds. Children and adolescents using ADHD medication showed a twofold risk for hospital admissions for injuries. ADHD drug use might diminish the increased injury risk, but still overall risk is higher than in age/sex sampled children and adolescents without treatment with ADHD drugs. Use of ADHD and concomitant psychotropics increases the risk for injuries compared to only ADHD drug use.
Similar content being viewed by others
References
American Academy of Child and Adolescent Psychiatry (2002) Practice parameter for the use of stimulant medications in the treatment of children, adolescents and adults. J Am Acad Child Adolesc Psychiatry 41(suppl 2):26S–49S
Graham J, Banaschewski T, Buitelaar J et al (2011) European guideline on managing adverse effects of medication for ADHD. Eur Child Adolesc Psychiatry 20:17–37
Brown R, Pacini J (1989) Perceived family functioning, marital status, and depression in parents of boys with attention deficit disorder. J Learn Disabil 22:581–587
Barkley R, Guevremont D, Anastopoulos A et al (1993) Driving-related risks and outcomes of attention deficit hyperactivity disorder in adolescents and young adults: a 3- to 5-year follow-up survey. Pediatrics 92:212–218
Mannuzza S, Klein R, Bessler A et al (1993) Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry 50:565–576
Leibson C, Katusic S, Barbaresi W et al (2001) Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder. JAMA 285:60–66
Swensen A, Birnbaum H, Secnik K et al (2003) Attention-deficit/hyperactivity disorder: increased costs for patients and their families. J Am Acad Child Adolesc Psychiatry 42:1415–1423
Swensen A, Birnbaum H, Hamadi R, Greenberg P, Cremieux P, Secnik K (2004) Incidence and costs of accidents among attention/deficit disorder patients. J Adolesc Health 35:346e1–346e9
Wilens T (2004) Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues. Psychiatr Clin N Am 27:283–301
Matza L, Paramore C, Prasad M (2005) A review of the economic burden of ADHD. Cost Eff Resour Alloc 3:5–13
Hakkaart-van Roijen L, Zwirs B, Bouwmans C et al (2007) Social costs and quality of life of children suffering from attention deficit hyperactivity disorder (ADHD). Eur Child Adolesc Psychiatry 16:316–326
Coghill D, Soutello C, Aubuisson C et al (2008) Impact of attention-deficit/hyperactivity disorder on the patient and family: results from a European survey. Child Adolesc Psychiatry Ment Health (serial online) 28(2):31–46
Sobanski E, Brüggemann D, Alm B et al (2008) Subtype differences in adults with attention-deficit/hyperactivity disorder (ADHD) with regard to ADHD-symptoms, psychiatric comorbidity and psychosocial adjustment. Eur Psychiatry 23:142–149
Meyers J, Classi P, Wietecha L et al (2010) Economic burden and comorbidities of attention-deficit/hyperactivity disorder among pediatric patients hospitalized in the United States. Child Adolesc Psychiatry Ment Health 14:31
DiScala C, Lescohier I, Barthel M, Li G (1998) Injuries to children with attention deficit hyperactivity disorder. Pediatrics 102:1415–1421
Barkley R (2002) ADHD and accident proneness. ADHD Rep 2:2–6
Brehaut J, Miller A, Raina P, McGrail K (2003) Childhood behavior disorders and injuries among children and youth: a population-based study. Pediatrics 111:262–269
Rowe R, Maughan B, Goodman R (2004) Childhood psychiatric disorder and unintentional injury: findings from a National Cohort Study. J Pediatr Psychol 29:119–130
Scharnetzky E, Schill W, Glaeske G, Jahnsen K (2004) Are children and youths with attention deficit/hyperactivity disorder (ADHD) accident prone? Pharmacoepidemiol Drug Saf 13:93
Brook U, Boaz M (2006) Adolescents with attention deficit and hyperactivity disorder/learning disability and their proneness to accidents. Indian J Pediatr 73:299–303
Pastor P, Reuben C (2006) Identified attention-deficit/hyperactivity disorder and medically attended, non fatal injuries: US school-age children, 1997–2002. Ambul Pediatr 6:38–44
Marcus S, Wan G, Zhang H, Olfson M (2008) Injury among stimulant treated youth with ADHD. J Atten Disord 12:64–69
Banaschewski T, Coghill D, Santosh P et al (2006) Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline. Eur Child Adolesc Psychiatry 15:476–495
Robison L, Sclar D, Traer T, Galin RS (1999) National trends in prevalence of attention-deficit/hyperactivity disorder and the prescription of methylphenidate among school-age children: 1990–1995. Clin Pediatr 38:209–217
Zito J, Safer D, dosReis S et al (2000) Trends in prescribing of psychotropic medications to preschoolers. JAMA 283:1025–1030
Zito J, Safer D, Satish Valluri M et al (2007) Psychotherapeutic medication prevalence in Medicaid-insured preschoolers. J Child Adolesc Psychofarmacol 17:195–203
Miller A, Lalonde C, McGrail K, Armstrong RW (2001) Prescription of methylphenidate to children and youth, 1990–1996. Can Med Assoc 165:1489–1494
Schirm E, Tobi H, Zito J, de Jong-van den Berg LT (2001) Psychotropic medication in children: a study from the Netherlands. Pediatrics 108:E25–E29
Reid R, Hakendorf P, Prosser B (2002) Use of stimulant medication for ADHD in South Australia. J Am Acad Child Adolesc Psychiatry 41:906–913
Vinker S, Vinker R (2006) Elhayany. A prevalence of methylphenidate use among Israeli children: 1998–2004. Clin Drug Invest 26:161–167
Winterstein A, Gerhard T, Shuster J et al (2008) Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database. Ann Pharmacother 42:24–31
van den Ban E, Souverein P, Swaab H, van Engeland H, Heerdink R, Egberts T (2010) Incidence and characteristics of children, adolescents, and adults initiating immediate- or extended-release methylphenidate or atomoxetine in the Netherlands during 2001–2006. J Child Adolesc Psychopharmacol 20:55–61
Hodgkins P, Sasane R, Meijer WM (2011) Pharmacologic treatment of attention-deficit/hyperactivity disorder in children: incidence, prevalence, and treatment patterns in the Netherlands. Clin Ther 33:188–203
Fliers E, Rommelse N, Vermeulen S (2008) Motor coordination problems in children and adolescents with ADHD rated by parents and teachers: effects of age and gender. J Neural Transm 115:211–220
Flapper B, Houwen S, Schoemaker M (2006) Fine motor skills and effects of methylphenidate in children with attention-deficit-hyperactivity disorder and developmental coordination disorder. Dev Med Child Neurol 48:165–169
Pless I, Taylor H, Arsenault L (1995) The relationship between vigilance deficits and traffic injuries involving children. Pediatrics 95:219–224
Pliszka S (1998) Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview. J Clin Psychiatr 59:50–58
Artigas-Pallares J (2003) Comorbidity in attention deficit hyperactivity disorder. Rev Neurol 36:68–78
Kutcher S, Aman N, Brooks S, Buitelaar J, van Daalen E, Fegert J (2004) International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behavior disorders (DBDs): clinical implications and treatment practice suggestions. Eur Neuropsychopharmacol 14:11–28
Stenbacka M, Jansson B, Leifman A, Romelsjö A (2002) Association between use of sedatives or hypnotics, alcohol consumption, or other risk factors and a single injurious fall or multiple injurious falls: a longitudinal general population study. Alcohol 28:9–16
French D, Campbell R, Spehar A, Angaran D (2005) Benzodiazepines and injury: a risk-adjusted model. Pharmacoepidemiol Drug Saf 114:17–24
Soubhi H, Raina P, Cohen D (2004) A neighborhood, family and child predictors of childhood injury in Canada. Am J Health Behav 28:397–409
Buitelaar J (2002) Epidemiological aspects: what have we learned over the last decade? In: Hyperactivity and attention disorders of childhood. Cambridge University Press, Cambridge
Buurma H, Bouvy M, De Smet P, Floor-Schreudering A, Leufkens H, Egberts A (2008) Prevalence and determinants of pharmacy shopping behaviour. J Clin Pharm Ther 33:17–23
Rosen B, Peterson L (1990) Gender differences in children’s outdoor play injuries: a review and integration. Clin Psychol Rev 10:187–205
Uslu M, Uslu R, Eksioglu F, Ozen N (2007) Children with fractures show higher levels of impulsive–hyperactive behavior. Clin Orthop Relat Res 460:192–195
Uslu M, Uslu R (2008) Extremity fracture characteristics in children with impulsive/hyperactive behavior. Arch Orthop Trauma Surg 128:417–421
Jensen P, Martin D, Cantwell D (1997) Comorbidity in ADHD: implications for research, practice and DSM-V. J Am Acad Child Adolesc Psychiatry 36:1065–1079
Gillberg C (1998) Hyperactivity, inattention and motor control problems: prevalence, comorbidity and background facts. Folia Phoniatr Logop 50:107–117
Kadesjö B, Gillberg C (1998) Attention deficits and clumsiness in Swedish 7-year-old children. Dev Med Child Neurol 40:796–804
Geuze R, Jongmans M, Schoemaker M, Smits-Engelsman B (2001) Developmental coordination disorder. Hum Mov Sci 20:1–5
Wilson P (2005) Practitioner review: approaches to assessment ant treatment of children with DCD: an evaluative review. J Child Psychol Psychiatry 46:806–823
Fliers E, Franke B, Lambregts-Rommelse N, Altink M, Buschgens C, Nijhuis-van der Sanden M (2010) Undertreatment of motor problems in children with ADHD. Child Adolesc Psychiatry Ment Health 15:85–90
Rubia K, Noorloos J, Smith A, Gunning B (2003) Motor timing deficits in community and clinical boys with hyperactive behavior: the effect of methylphenidate on motor timing. J Abnorm Child Psychol 31:301–313
de Zeeuw P (2011) Neurobiological heterogeneity in ADHD. Ibskamp drukkers BV, Enschede
Barkley R (1997) Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull 121:65–94
Rohde L, Biederman J, Busnello E et al (1999) ADHD in a school sample of Brazilian adolescents: a study of prevalence, comorbid conditions and impairments. J Am Acad Child Adolesc Psychiatry 38:716–722
Ford T, Goodman R, Meltzer H (2003) The British child and adolescent mental health survey 1999: the prevalence of DSM-IV disorders. J Am Acad Child Adolesc Psychiatry 42:1203–1211
Hurtig T, Ebeling H, Taanila A et al (2007) ADHD and comorbid disorders in relation to family environment and symptom severity. Eur Child Adolesc Psychiatry 16:362–369
Conner D, Glatt S, Lopez I, Jackson D, Melloni R (2002) Psychofarmacology and aggression I. A meta analysis of stimulant effects on overt-covert aggression-related behaviors in ADHD. J Am Acad Child Adolesc Psychiatry 41:253–261
Turgay A (2009) Psychopharmacological treatment of oppositional defiant disorder. CNS Drugs 23:1–17
Matthys W, Lochman J (2010) Oppositional defiant disorder and conduct disorder in childhood. Wiley-Blackwell, Chichester
Gaub M, Carlson C (1997) Gender differences in ADHD: a meta-analysis and critical review. J Am Acad Child Adolesc Psychiatry 36:1036–1045
Lee S, Humphreys K, Flory K, Liu R, Glass K (2010) Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review. Clin Psychol Rev 31:328–341
Ruel J, Hickey C (1992) Are too many children being treated with methylphenidate? Can J Psychiatry 37:570–572
Health Canada Reports (1999) Survey of attention deficit hyperactivity disorder (ADHD) diagnosis and treatment with methylphenidate among Canadian physicians. Health Canada, Ottawa
Conflict of interest
E.vdB.: Janssen-Cilag BV: advisory board, reimbursed travel to convention; Lilly Nederland BV: reimbursed travel to convention; UCB Pharma BV: reimbursed travel to convention; Eurocept BV: reimbursed travel to convention. The division of Pharmacoepidemiology and Clinical Pharmacology employing authors P.S., T.E. and E.H. has received unrestricted funding for pharmacoepidemiological research from GlaxoSmithKline, Novo Nordisk, the private–public funded Top Institute Pharma (http://www.tipharma.nl, includes co-funding from universities, government, and industry), the Dutch Medicines Evaluation Board, and the Dutch Ministry of Health. No support or funding for this manuscript. The PHARMO Institute for Drug Outcomes Research performs financially supported studies for several pharmaceutical companies. No support or funding for this manuscript. The other authors W.M., H.vE and H.S. have no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
van den Ban, E., Souverein, P., Meijer, W. et al. Association between ADHD drug use and injuries among children and adolescents. Eur Child Adolesc Psychiatry 23, 95–102 (2014). https://doi.org/10.1007/s00787-013-0432-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00787-013-0432-8